Analytical Data
-
基因名
HTRA1
- Application
-
别名
HtrA; L56; ORF480; PRSS11; HtrA Serine Peptidase 1; Protease,Serine,11; IGFBP5-Protease; High-temperature requirement A serine peptidase 1
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92743
-
表达区间
Gly204~Leu364
-
分子量
47kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HTRA1 (high-temperature requirement A1) is a serine protease known for its role in various biological processes, including protein quality control, apoptosis, and cellular stress responses. The gene encoding HTRA1 has garnered significant attention due to its association with age-related diseases, particularly in the context of ocular health, such as age-related macular degeneration (AMD). Mutations and alterations in HTRA1 expression have been implicated in the pathogenesis of AMD, leading to degeneration of retinal pigment epithelial cells and vision loss. Additionally, HTRA1 has been shown to influence extracellular matrix remodeling and regulatory pathways, thereby playing a crucial role in the development of fibrotic diseases and certain cancers. Research on HTRA1 recombinant proteins aims to elucidate its functional mechanisms in both health and disease. By producing HTRA1 in a laboratory setting, scientists can investigate its proteolytic activity, interactions with various substrates, and overall impact on cellular homeostasis. This knowledge could pave the way for novel therapeutic strategies targeting HTRA1-related pathways, with potential implications for treating AMD and other related disorders. Thus, the study of HTRA1 recombinant protein not only advances our understanding of its biochemistry but also holds promise for developing interventions aimed at mitigating diseases linked to its dysfunction.












